Volume 1, Issue 1 (Journal of Clinical and Basic Research (JCBR) 2017)
jcbr 2017, 1(1): 1-10 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Zhand S, Bazuori M, Tabarraei A, Moradi A. Molecular Epidemiology of Hepatitis C Virus Genotypes in Patients with Thalassemia Major in Golestan Province, Iran. jcbr 2017; 1 (1) :1-10
URL: http://jcbr.goums.ac.ir/article-1-21-en.html
URL: http://jcbr.goums.ac.ir/article-1-21-en.html
Abstract: (5346 Views)
ABSTRACT
Introduction: In Iran, hepatitis C virus (HCV) is the most prevalent cause of chronic hepatitis and cirrhosis in patients with hemophilia, thalassemia, and renal failure. Recent studies suggest that patients infected with different HCV genotypes have different clinical profiles, severity of liver disease and response to therapy. Several molecular methods targeting different HCV genomic regions have been introduced for genotyping. Direct sequencing of amplified PCR products is the gold standard method, followed by phylogenetic analysis of clinical material. The aim of this study was to determine genotypes of HCV-infected patients with thalassemia in Golestan Province, Iran. Materials and Methods: This cross-sectional study included 217 patients (mean age: 21.82 ± 16 years, 50.7% male) with thalassemia major. Enzyme-linked immunosorbent assay (ELISA) was used for detection of HCV antibodies. Positive HCV-Ab samples were confirmed by reverse transcription polymerase chain reaction (RT-PCR) and sequencing. HCV genotypes were determined by aligning nucleotide sequences of patients with the standard nucleotide sequences obtained from GenBank (accession number: AB520610). Results: Of 217 patients with thalassemia major, 14 (6.45%) were found as anti-HCV-positive in the ELISA test. Among them, two patients (14.28%) had positive RT-PCR results. In addition, all patients were infected with HCV genotype 1a. Conclusions: Genotype 1a is the predominant HCV genotype in patients with thalassemia major in the Golestan province, Iran.
KEYWORDS: Hepatitis C virus, Genotype, Thalassemia major, Golestan Province
Article Type: Research |
Subject:
Statistics and epidemiology
References
1. Abdel-Hamid M, El-Daly M, Molnegren V, El-Kafrawy S, Abdel-Latif S, Esmat G, et al. Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma. Journal of general virology. 2007;88(5):1526-31. [DOI:10.1099/vir.0.82626-0]
2. Alavian S, Kafaee J, Yektaprast B, Hajarizadeh B, Doroudi T. The efficacy of blood donor screening in reducing the incidence of hepatitis C virus infection among thalassemic patients in Iran. TRANSFUSION TODAY. 2002;3-4.
3. Ahmadi Pour M, Keivani H, Sabahi F, Alavian S. Determination of HCV genotypes in Iran by PCR-RFLP. Iranian J Publ Health. 2006;35(4):54-61.
4. Zein NN. Clinical significance of hepatitis C virus genotypes. Clinical microbiology reviews. 2000;13(2):223-35. [DOI:10.1128/CMR.13.2.223-235.2000]
5. Moradpour D, Cerny A, Heim MH, Blum HE. Hepatitis C: an update. Swiss medical weekly. 2001;131(21-22):291-8.
6. Matera G, Lamberti A, Quirino A, Focà D, Giancotti A, Barreca GS, et al. Changes in the prevalence of hepatitis C virus (HCV) genotype 4 in Calabria, Southern Italy. Diagnostic microbiology and infectious disease. 2002;42(3):169-73. [DOI:10.1016/S0732-8893(01)00350-9]
7. Campiotto S, Pinho J, Carrilho F, Da Silva L, Souto F, Spinelli V, et al. Geographic distribution of hepatitis C virus genotypes in Brazil. Brazilian Journal of Medical and Biological Research. 2005;38(1):41-9. [DOI:10.1590/S0100-879X2005000100007]
8. Farci P, Purcell RH, Clinical significance of hepatitis C virus genotypes and quasispecies. Seminars in Liver Diseases; 2000: Seminars in Liver Disease 20(1):103-26 •
9. Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proceedings of the National Academy of Sciences. 1990;87(24):9524-8. [DOI:10.1073/pnas.87.24.9524]
10. Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, Melpolder JC, et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science. 2000;288(5464):339-44. [DOI:10.1126/science.288.5464.339]
11. Genovese D, Dettori S, Argentini C, Villano U, Chionne P, Angelico M, et al. Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis. Journal of clinical microbiology. 2005;43(4):1902-9. [DOI:10.1128/JCM.43.4.1902-1909.2005]
12. Simmonds P, Mellor J, Sakuldamrongpanich T, Nuchaprayoon C, Tanprasert S, Holmes E, et al. Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. Journal of general virology. 1996;77(12):3013-24. [DOI:10.1099/0022-1317-77-12-3013]
13. Omran MH, Youssef SS, El-Garf WT, Tabll AA, Bader-Eldin NG, Atef K, et al. Phylogenetic and genotyping of hepatitis C virus in Egypt. Microbiology. 2009;3:1-8.
14. Farivar TN, Nezam MK, Johari P. Genotyping of hepatitis C virus isolated from hepatitis patients in Southeast of Iran by Taqman Realtime PCR. JPMA The Journal of the Pakistan Medical Association. 2011;61(6):586.
15. Jimenez-Mendez R, Uribe-Salas F, López-Guillen P, Cisneros-Garza L, Casta-eda-Hernandez G. Distribution of HCV genotypes and HCV RNA viral load in different regions of Mexico. Ann Hepatol. 2010;9(1):33-9.
16. Narahari S, Juwle A, Basak S, Saranath D. Prevalence and geographic distribution of Hepatitis C Virus genotypes in Indian patient cohort. Infection, Genetics and Evolution. 2009;9(4):643-5. [DOI:10.1016/j.meegid.2009.04.001]
17. Farshadpour F, Makvandi M, Samarbafzadeh A, Jalalifar M. Determination of hepatitis C virus genotypes among blood donors in Ahvaz, Iran. Indian Journal of Medical Microbiology. 2010;28(1):54. [DOI:10.4103/0255-0857.58731]
18. Mahaney K, Tedeschi V, Maertens G, Di Bisceglie AM, Vergalla J, Hoofnagle JH, et al. Genotypic analysis of hepatitis C virus in American patients. Hepatology. 1994;20(6):1405-11. [DOI:10.1002/hep.1840200605]
19. McOmish F, Chan S, Dow B, Gillon J, Frame W, Crawford R, et al. Detection of three types of hepatitis C virus in blood donors: investigation of type‐specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion. 1993;33(1):7-13. [DOI:10.1046/j.1537-2995.1993.33193142314.x]
20. Viazov S, Kuzin S, Paladi N, Tchernovetsky M, Isaeva E, Mazhul L, et al. Hepatitis C virus genotypes in different regions of the former Soviet :union: (Russia, Belarus, Moldova, and Uzbekistan). Journal of medical virology. 1997;53(1):36-40.
https://doi.org/10.1002/(SICI)1096-9071(199709)53:1<36::AID-JMV7>3.0.CO;2-R [DOI:10.1002/(SICI)1096-9071(199709)53:13.0.CO;2-R]
21. Nousbaum J-B, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C. Hepatitis C virus type 1b (II) infection in France and Italy. Annals of internal medicine. 1995;122(3):161-8. [DOI:10.7326/0003-4819-122-3-199502010-00001]
22. Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL. Genetic epidemiology of hepatitis C virus throughout Egypt. Journal of Infectious Diseases. 2000;182(3):698-707. [DOI:10.1086/315786]
23. Xu L-Z, Larzul D, Delaporte E, Bréchot C, Kremsdorf D. Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon). The Journal of general virology. 1994;75:2393. [DOI:10.1099/0022-1317-75-9-2393]
24. Njouom R, Pasquier C, Ayouba A, Gessain A, Froment A, Mfoupouendoun J, et al. High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon. Journal of medical virology. 2003;71(2):219-25. [DOI:10.1002/jmv.10473]
25. Smuts H, Kannemeyer J. Genotyping of hepatitis C virus in South Africa. Journal of clinical microbiology. 1995;33(6):1679-81.
26. Mellor J, Walsh E, Prescott L, Jarvis L, Davidson F, Yap P, et al. Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay. Journal of clinical microbiology. 1996;34(2):417-23.
27. Zali MR, Mayumi M, Raoufi M, Nowroozi A. Hepatitis C virus genotypes in the Islamic Republic of Iran: a preliminary study. Eastern Mediterranean Health Journal. 2000;6:372-7.
28. Samimi‐Rad K, Nategh R, Malekzadeh R, Norder H, Magnius L. Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region. Journal of medical virology. 2004;74(2):246-52. [DOI:10.1002/jmv.20170]
29. Samimi‐rad K, Shahbaz B. Hepatitis C virus genotypes among patients with thalassemia and inherited bleeding disorders in Markazi province, Iran. Haemophilia. 2007;13(2):156-63. [DOI:10.1111/j.1365-2516.2006.01415.x]
30. Somi MH, Keivani H, Ardalan MR, Farhang S, Pouri AA. Hepatitis C virus genotypes in patients with end-stage renal disease in East Azerbaijan, Iran. Saudi Journal of Kidney Diseases and Transplantation. 2008;19(3):461.
31. Moradi A, Semnani S, Keshtkar A, Khodabakhshi B, Kazeminejad V, Molana A, et al. Distribution of Hepatitis C Virus Genotype among HCV Infected Patients in Golestan Province, Iran. Govaresh. 2011;15(1):7-13.
32. Bozdayi G, Rota S, Verdi H, Derici U, Sindel S, Bali M, et al. The presence of hepatitis C virus (HCV) infection in hemodialysis patients and determination of HCV genotype distribution. Mikrobiyoloji bülteni. 2002;36(3-4):291.
33. Selcuk H, Kanbay M, Korkmaz M, Gur G, Akcay A, Arslan H, et al. Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment. Digestive diseases and sciences. 2006;51(8):1420-5. [DOI:10.1007/s10620-005-9025-9]
34. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol. 1992;73(Pt 3):673-9. [DOI:10.1099/0022-1317-73-3-673]
35. Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR, et al. Seroprevalence of hepatitis C virus: the first population-based study from Iran. International Journal of Infectious Diseases. 2010;14:e113-e6. [DOI:10.1016/j.ijid.2009.11.032]
36. Annemarie Wasley SD, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Hepatitis C: State of the Art at the Millennium. 2000;20(1):1. [DOI:10.1055/s-2000-9506]
37. Tajbakhsh E, Dosti A, Tajbakhsh S, Momeni M, Tajbakhsh F. Determination of hepatitis C virus genotypes among HCV positive patients in Shahrekord, Iran. African Journal of Microbiology Research. 2011;5(32):5910-5. [DOI:10.5897/AJMR11.942]
38. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244(4902):359-62. [DOI:10.1126/science.2523562]
39. Pavio N, Lai MM. The hepatitis C virus persistence: how to evade the immune system? Journal of biosciences. 2003;28(3):287-304. [DOI:10.1007/BF02970148]
40. Elahi E, Pourmand N, Chaung R, Rofoogaran A, Boisver J, Samimi-Rad K, et al. Determination of hepatitis C virus genotype by Pyrosequencing. Journal of virological methods. 2003;109(2):171-6. [DOI:10.1016/S0166-0934(03)00068-5]
41. Hashemi SJ, Masjedizadeh A, Shayesteh AA, Jalali F. Genotypic Analysis of Hepatitis C Virus in Khuzestan Province, Southwestern Iran. Middle East Journal of Digestive Diseases (MEJDD). 2011;3(2):126-30.
42. Mirmomen S, Alavian S-M, Hajarizadeh B, Kafaee J, Yektaparast B, Zahedi M-J, et al. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study. Arch Iran Med. 2006;9(4):319-23.
43. Younus M, Hassan K, Ikram N, Naseem L, Zaheer HA, Khan MF. Hepatitis C virus seropositivity in repeatedly transfused thalassemia major patients. Int J Pathol. 2004;2(1):20-3.
44. Bhavsar H, Patel K, Vegad M, Madan M, Pandey A, Asthana A, et al. Prevalence of HIV, Hepatitis B and Hepatitis C infection in Thalassemia major patients in tertiary care hospital, Gujarat. National Journal of Integrated Research in Medicine. 2011;2(3):47-51.
45. 45.Williams T, Wonke B, Donohue S. A study of hepatitis B and C prevalence and liver function in mutiply transfused thalassemic and their parents. Indian pediatrics. 1992;29(9):1119-24.
46. Shah S, Khan MT, Ullah Z. Hepatitis-B and Hepatitis-C virus infection in multi-transfused thalassemia Major patients. Pakistan journal of medical sciences. 2005;21(3):281.
47. Wanachiwanawin W, Luengrojanakul P, Sirangkapracha P, Leowattana W, Fucharoen S. Prevalence and clinical significance of hepatitis C virus infection in Thai patients with thalassemia. International journal of hematology. 2003;78(4):374-8. [DOI:10.1007/BF02983565]
48. Khalifa A, Mitchell BS, Watts DM, El-Samahy MH, El-Sayed MH. Prevalence of hepatitis C viral antibody in transfused and nontransfused Egyptian children. DTIC Document; 1993.
49. Wonke B, Hoffbrand A, Brown D, Dusheiko G. Antibody to hepatitis C virus in multiply transfused patients with thalassaemia major. Journal of clinical pathology. 1990;43(8):638-40. [DOI:10.1136/jcp.43.8.638]
50. Oza T, Agrawat A, Dhruva G, Oza H. A Study Of Prevalence Of HIV, HbsAg And HCV In Thalassemia Major Children. National Journal of Integrated Research in Medicine. 2012;3(4):114-7.
51. Alavian SM, Tabatabaei S, Lankarani K. Epidemiology of HCV infection among thalassemia patients in eastern Mediterranean countries: a quantitative review of literature. Iranian Red Crescent Medical Journal. 2010;12(4):365-76.
52. Tamaddoni A, Mohammadzadeh I, Ziaei O. Seroprevalence of HCV antibody among patients with β-thalassemia major in Amirkola Thalassemia center, Iran. Iranian Journal of Allergy, Asthma and Immunology. 2007;6(1).
53. Kashanchi Langarodi M, Abdolrahim Poorheravi H. Prevalence of HCV among thalassemia patients in Shahid Bahonar Hospital, Karaj. Blood (khoon). 2011.
54. Ataei B, Hashemipour M, Kassaian N, Hassannejad R, Nokhodian Z, Adibi P. Prevalence of Anti HCV Infection in Patients with Beta-Thalassemia in Isfahan-Iran. International journal of preventive medicine. 2012;3(Suppl1):S118.
55. Kabir A, Alavian S-M, Keyvani H. Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study. Comp Hepatol. 2006;5(4):17014721.
56. Park J-C, Kim J-M, Kwon O-J, Lee K-R, Chai Y-G, Oh H-B. Development and clinical evaluation of a microarray for hepatitis C virus genotyping. Journal of virological methods. 2010;163(2):269-75. [DOI:10.1016/j.jviromet.2009.10.008]
57. Keyvani H, Alizadeh AH, Alavian SM, Ranjbar M, Hatami S. Distribution frequency of hepatitis C virus genotypes in 2231 patients in Iran. Hepatology Research. 2007;37(2):101-3. [DOI:10.1111/j.1872-034X.2007.00015.x]
58. Safieh A, MahmoodMahmoodiFarahani MA, Mahsa J, MalekHossein A. Distribution of hepatitis C virus genotypes in Iran: a population-based study. Hepatitis monthly. 2009;2009(2, Spring):95-102.
59. Pawlotsky JM, Chevaliez S. Preventing hepatitis C virus recurrence in liver transplant recipients: A role for adoptive immunotherapy? Hepatology. 2010;51(3):1072-6. [DOI:10.1002/hep.23579]
60. Hosseini‐Moghaddam SM, Keyvani H, Kasiri H, Kazemeyni SM, Basiri A, Aghel N, et al. Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran—a multicenter study. Journal of medical virology. 2006;78(5):569-73. [DOI:10.1002/jmv.20577]
61. Yu ML, Chuang WL. Treatment of chronic hepatitis C in Asia: when East meets West. Journal of gastroenterology and hepatology. 2009;24(3):336-45. [DOI:10.1111/j.1440-1746.2009.05789.x]
62. Ziyaeyan M, Alborzi A, Jamalidoust M, Badiee P, Moeini M, Kadivar A. Prevalence of hepatitis C virus genotypes in chronic infected patients, southern Iran. Jundishapur Journal of Microbiology. 2011;4(3):141-6.
63. Schröter M, Zöllner B, Laufs R, Feucht H-H. Changes in the prevalence of hepatitis C virus genotype among injection drug users: a highly dynamic process. Journal of Infectious Diseases. 2004;190(6):1199-200. [DOI:10.1086/423622]
64. Nakano T, Lu L, Liu P, Pybus OG. Viral gene sequences reveal the variable history of hepatitis C virus infection among countries. Journal of Infectious Diseases. 2004;190(6):1098-108. [DOI:10.1086/422606]
65. Kazemi B, Tafvizi F, Bandehpour M. Determination of HCV genotypes in Iran. Biotechnology. 2005;4(2):139-43. [DOI:10.3923/biotech.2005.139.143]
66. Mousavi SF, Moosavy SH, Alavian SM, Eghbali H, Mahboobi H. Distribution of hepatitis C virus genotypes among patients with hepatitis C virus infection in hormozgan, iran. Hepatitis monthly. 2013;13(12). [DOI:10.5812/hepatmon.14324]
67. Idrees M, Riazuddin S. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infectious Diseases. 2008;8(1):69. [DOI:10.1186/1471-2334-8-69]
68. Hajia M, Amirzargar A, Khedmat H, Shahrokhi N, Farzanehkhah M, Ghorishi S, et al. Genotyping pattern among Iranian HCV positive patients. Iranian journal of public health. 2010;39(2):39.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).